Breast centers: Rationale, functional concept, definition, and certification;Brustzentren: Rationale, funktionelles Konzept, Definition und Zertifizierung

Gynakologe

Volumn 36, Issue 10, 2003, Pages 862-877

  Brucker, S ^b   Krainick, U ^b   Bamberg, M ^b   Aydeniz, B ^b   Wagner, U ^b   Du Bois, A ^b   Claussen, C ^b   Kreienberg, R ^b   Wallwiener, D ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b NONE

Author keywords

Breast cancer; Breast center; Certification; Guidelines; Quality management

Indexed keywords

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER SURGERY; CERTIFICATION; COMPETENCE; MEDICAL SPECIALIST; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; SURVIVAL RATE;

EID: 0142167527     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00129-003-1426-2     Document Type: Review

References (37)

1. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland und Robert-Koch-Institut (2002) Krebs in Deutschland, Häufigkeit und Trends. 3. erweiterte Ausgabe
2. Krainick U, Meyberg-Solomayer, Majer I et al. (2002) Minimal invasive Mammabiopsien: Die Vakuumbiopsie (VB) mit dem Handheld (HH) Mammotome™ unter Ultraschallsicht - Erfahrungen und Indikationsspektrum des Brustzentrums Tübingen. Geburtsh Frauenheilk 62: 346-350
3. Grischke EM, Wallwiener D (2000) Das Mammakarzinom an der Schwelle zum neuen Jahrtausend. Gynäkologie 33: 757-763
4. Wallwiener D (2000) Aktuelle Aspekte in der Behandlung des Mammkarzinoms. Med Welt 1: 5-6
5. Wallwiener D, Diel IJ, Solomayer EF et al. (1998) Neoadjuvante Chemotherapie bei lokal fortgeschrittenen Mammakarzinomen: Tumorregression und perioperative Komplikationen. Geburtsh Frauenheilk 58: 44-50
6. Kühn T, Ostertag H, Bauerfeind I, Untch M, Jonat W, Wallwiener D, Kreienberg R (2002) Sentinel-Node-Biopsie beim Mammakarzinom. Frauenarzt 43: 1324-1328
7. Diesing D, Hönig A, Fersis N, Sotlar K, Bültmann B, Diedrich K, Wallwiener D (2003) Sentinel node biopsy in breast cancer specifies but does not (yet) replace axillary lymphonodectomy. Geburtsh Frauenheilk (im Druck)
8. Wulfkuhle J, Sgroi D, Kruztsch H (2002) Proteomics in human breast ductal carcinoma in situ (DCIS). Cancer Res 62: 6740-6749
9. Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bode S, Wallwiener D, Bastert G (1998) Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancer. Breast Cancer Res Treat 49: 145-154
10. Berrino F, Sant M, Verdecchia A et al. (Hrsg) (1995) Survival of cancer patients in Europe: the EUROCARE study. IARC Scientific Publications No. 132, Lyon
11. Berrino F, Capocaccia R, Esteve J et al. (Hrsg) (1999) Survival of cancer patients in Europe: the EUROCARE study. IARC Scientific Publications No. 151, Lyon
12. Kampfgegen den Krebs (2002) Spiegel 15/2002
13. Roohan PJ, Bickell NA, Baptiste MS, Therriault GD, Ferrara EP, Siu al. (1998) Hospital volume differences and five-year survival from breast cancer. Am J Public Health 88: 454-457
14. Gillis CR, Hole DJ (1996) Survival outcome of care by specialist surgeons in breast cancer: a study of 3768 patients in the west of Scotland. BMJ 312: 145-148
15. Sainsbury R, Howard B, Rider L, Johnston C, Round C (1995) Influence of clinician workload and pattern of treatment on survival from breast cancer: Lancet 345: 1265-1270
16. Richards M, Sainsbury R, Kerr D (1997) Inequalities in breast cancer care and outcome. Br J Cancer 76: 634-638
17. Grilli R, Minozzi S, Tinazzi A, Labianca R, Sheldon TA, Liberari A (1998) Do specialists do it better? The impact of specialization on the processes and outcomes of care for cancer patients. Ann Oncol 9: 365-374
18. Golledge J, Wiggins JE, Callam MJ (2000) Effect of surgical subspecialization on breast cancer outcome. Br J Surg 87: 1420-1425
19. Ma M, Bell J, Campbell S, Basnett I, Pollock A, Taylor I (1997) Breast cancer management: is volume related to quality? Clinical Advisory panel. Br J Cancer 75: 1652-1659
20. Hillner BE, Smith TJ, Desch CE (2000) Hospital and physician volume or specialization and outcome in cancer treatment: importance in quality of cancer care. J Clin Oncol 18: 2327-2340
21. Cady B, Falkenberry S, Chung MA (2000) The surgeon's role in outcome in contemporary breast cancer. Surg Oncol Clin 9: 119-132
22. Luft HS, Hunt SS, Maerki SC (1987) The volume-outcome relationship: practice makes perfect or selective referral pattern? Health Serv Res 22: 157-182
23. Hughes RG, Hunt SS, Luft HS (1987) Effects of surgeon volume and hospital volume on quality of care in hospitals. Med care 25: 489-503
24. Du Bois A, Misselwitz B, Stillger R et al. (2003) Versorgungsstruktur und Qualität bei der Behandlung des Mammakarzinoms. Geburtsh Frauenheilk (im Druck)
25. Engel J, Nagel G, Breuer E et l. (2002) Primary breast cancer therapy in six regions of Germany. Eur J Cancer 38: 578-585
26. Early Breast Cancer Trialists Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials invoving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339: 1-15
27. Gnant M on behalf of the Austrian Breast & Colorectal Cancer Study Group (2000) Impact of participation in randomized clinical trials on survival of women with early stage breast cancer. Proc Am Soc Clin Oncol 19: 74a
28. Du Bois A, Pfisterer, Kellermann L, Kreienberg R (2000) Die Therapie des fortgeschrittenen Ovarialkarzinoms in Deutschland: welchen Einfluss hat die Teilnahme an klinischen Studien? Geburtsh Frauenheilk 61: 863-871
29. European Society of Mastology (EUSOMA) Guidelines (2000) The requirements of a specialist breast unit. Eur J Cancer 36: 2288-2293
30. King's Fund (1986) Consensus development conference: treatment of primary breast cancer. BMJ 293: 946-947
31. McKee MD, Cropp MD, Hyland A et al. (2002) Provider case volume and outcome in the evaluation and treatment of patients with mammogram-detected breast carcinoma. Cancer 95: 704-712
32. Kotwall CA, Covington DL, Rutlege R, Churchill MP, Meyer AA (1996) Patient, hospital, and surgeon factors associated with breast conservation surgery. Ann Surg 224: 419-429
33. Chief Medical Officers'expert advisory group on cancers (1995) A policy framework for commissioning cancer services. Department of Health and Welsh Office, London
34. Kreienberg R, Volm T, Schmitt-Thomas B auf der Basis der Checkliste für Brustzentren von Sänger S und Höffken K vom 15.11.2000. Fachliche Anforderungen für die Zertifizierung von Brustzentren durch die Deutsche Krebsgesellschaft und die Deutsche Gesellschaft für Senologie. Erhebungsbogen für Brustzentren der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Senologie
35. Bender HG, Schwenzer T, Weyergraf HJ, Wallwiener D (2000) Operative Gynäkologie: Qualitätssicherung. Z Geburtsh Frauenhkd Suppl 2
36. Geraedts M, Neumann M (2003) Qualitätssicherung: Mindestmenge als alleiniger Qualitätsindikator unzureichend. Dtsch Arztebl 100: A 381-384
37. Peto R, Boreham J, Clarke M, Davies C, Beral V (2000) UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 355: 1822